Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.29 USD
Change Today -2.31 / -9.79%
Volume 3.5M
MDAS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

medassets inc (MDAS) Snapshot

Open
$22.45
Previous Close
$23.60
Day High
$23.42
Day Low
$21.11
52 Week High
07/30/15 - $23.90
52 Week Low
02/18/15 - $17.00
Market Cap
1.3B
Average Volume 10 Days
1.3M
EPS TTM
$0.63
Shares Outstanding
60.0M
EX-Date
--
P/E TM
33.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDASSETS INC (MDAS)

medassets inc (MDAS) Related Bloomberg News

View More Bloomberg News

medassets inc (MDAS) Related Businessweek News

View More BusinessWeek News

medassets inc (MDAS) Details

MedAssets, Inc., a performance improvement company, provides technology-enabled products and services for hospitals, health systems, non-acute healthcare providers, payers, and other service providers and product manufacturers in the United States. It operates in two segments, Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment provides a suite of cost management services, supply chain analytics, and data capabilities; strategic sourcing and group purchasing services; and medical device and clinical resource consulting, lean performance improvement, workforce management, and supply chain outsourcing and procurement services. This segment also provides business intelligence and decision support tools. The RCM segment offers Web-based software and technology-enabled services designed to enhance the revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable, and outsourcing services. As of December 31, 2014, the company served approximately 4,500 acute care hospitals and 123,000 ancillary or non-acute provider locations. The company was incorporated in 1999 and is headquartered in Alpharetta, Georgia.

3,350 Employees
Last Reported Date: 03/2/15
Founded in 1999

medassets inc (MDAS) Top Compensated Officers

President, Chief Operating Officer and Direct...
Total Annual Compensation: $577.2K
Founder and Chairman Emeritus
Total Annual Compensation: $898.1K
President of Revenue Cycle Management Segment
Total Annual Compensation: $555.0K
Chief Customer Officer, Senior Executive Vice...
Total Annual Compensation: $578.8K
Chief Strategy & Transformation Officer and E...
Total Annual Compensation: $470.3K
Compensation as of Fiscal Year 2014.

medassets inc (MDAS) Key Developments

MedAssets Is Exploring Available Strategic Alternatives

MedAssets, Inc. (NasdaqGS:MDAS) plan to create significant shareholder value by reducing its operating expenses, improving capital allocation, improving corporate governance and exploring all available strategic alternatives.

MedAssets, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Third Quarter of 2015; Revised Earnings Guidance for the Year Ending December 31, 2015

MedAssets, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company's total net revenue was $190,424,000 compared to $175,415,000 a year ago. Excluding the revenue contribution from Sg2 (acquired on September 22, 2014), total net revenue growth was 1.8% on a year-over-year basis. Operating income was $23,563,000 compared to $22,273,000 a year ago. Income before income taxes was $11,643,000 compared to $11,190,000 a year ago. Net income was $6,314,000 compared to $6,596,000 a year ago. Diluted net income per share was $0.10 compared to $0.11 a year ago. Total non-GAAP adjusted EBITDA was $59,137,000 compared to $54,324,000 a year ago. The increase was due to growth in net revenue in addition to improved operating efficiencies in revenue cycle services. Non-GAAP EBITDA was $52,924,000 compared to $48,841,000 a year ago. Non-GAAP adjusted net income was $19,066,000 compared to $18,368,000 a year ago. Non-GAAP adjusted EPS - diluted was $0.31 compared to $0.30 a year ago. For the six months, the company's total net revenue was $376,005,000 compared to $346,282,000 a year ago. Excluding the contribution from Sg2, full-year total net revenue growth was 2.1% when compared with the first six months of 2014. Operating income was $40,973,000 compared to $47,053,000 a year ago. Income before income taxes was $17,246,000 compared to $24,855,000 a year ago. Net income was $9,667,000 compared to $14,274,000 a year ago. Diluted net income per share was $0.16 compared to $0.23 a year ago. Cash provided by operating activities was $81,243,000 compared to $50,789,000 a year ago. Purchases of property, equipment, and software was $3,135,000 compared to $7,201,000 a year ago. Capitalized software development costs was $19,848,000 compared to $20,878,000 a year ago. Total non-GAAP adjusted EBITDA was $116,510,000 compared to $111,041,000 a year ago. Non-GAAP EBITDA was $99,775,000 compared to $99,669,000 a year ago. Non-GAAP adjusted net income was $37,832,000 compared to $38,061,000 a year ago. Non-GAAP adjusted EPS - diluted was $0.62 compared to $0.62 a year ago. Consolidated net revenue is expected to be $184.1 million to $190.1 million, up 4.8% to 8.2% from $175.7 million reported in the third quarter of 2014. The company expects GAAP EPS to be in the range of $0.01 to $0.05 per share and adjusted EPS is expected to be down 14.8% to 26.5% from third quarter 2014 adjusted EPS of $0.34. The company raised the midpoints of its full-year ending December 31, 2015 consolidated financial guidance, realigned the segment revenue mix based on year-to-date results, and narrowed the guidance ranges. For the year, the company expects total net revenue to be in the range of $756 million to $768 million, net income to be in the range of $17,300,000 to $20,800,000, depreciation of $56,800,000, amortization of intangibles of $58,800,000, interest expense, net of $47,600,000, non-GAAP EBITDA to be in the range of $197,000,000 to $203,000,000, non-GAAP adjusted EBITDA to be in the range of $232,000,000 to $238,000,000, EPS diluted to be in the range of $0.28 to $0.34 and non-GAAP adjusted EPS - diluted to be in the range of $1.20 to $1.26. The company used a tax rate of 40.0% for the full year ending December 31, 2015 to calculate the tax effect of each adjustment since it believes 40.0% will be the Company's normalized long-term tax rate.

MedAssets, Inc. to Report Q2, 2015 Results on Jul 29, 2015

MedAssets, Inc. announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Jul 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDAS:US $21.29 USD -2.31

MDAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMN Healthcare Services Inc $30.14 USD +0.45
Huron Consulting Group Inc $76.03 USD +0.74
Quality Systems Inc $12.59 USD -0.07
WebMD Health Corp $43.92 USD -0.80
WNS Holdings Ltd $30.42 USD +0.34
View Industry Companies
 

Industry Analysis

MDAS

Industry Average

Valuation MDAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.9x
Price/Book 3.1x
Price/Cash Flow 16.4x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDASSETS INC, please visit www.medassets.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.